SAINT BELLA GROUP LIMITED (abbreviated “SAINT BELLA GP”) repurchased 70,000 ordinary shares on 30 September 2026 under its Hong Kong-listed buyback mandate, according to a Next Day Disclosure Return filed on 2 October 2026. The purchase was conducted on the Stock Exchange of Hong Kong and all acquired shares were retained as treasury stock. ​

The repurchase was executed within a price range of HKD 2.68–2.80 per share, translating into a volume-weighted average of approximately HKD 2.76. Aggregate consideration amounted to HKD 0.19 million.

Following the transaction, the company’s issued share capital (excluding treasury shares) declined by 70,000 shares, or 0.0114%, to 615.88 million. Treasury shares increased to 6.32 million, keeping total issued shares unchanged at 622.20 million.

The buyback forms part of the mandate approved on 30 June 2026, which authorises the repurchase of up to 62.22 million shares. To date, SAINT BELLA GP has repurchased 6.32 million shares, equivalent to 1.02% of the issued share base at the mandate date, leaving roughly 55.90 million shares available for further repurchase.

A 30-day moratorium on new share issues or sales/transfer of treasury shares is in force until 30 October 2026, as required by Hong Kong listing regulations. The company confirmed that the repurchase complied with Main Board Rule 10.06 and that no material changes have been made to its previously filed explanatory statement.